PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
22-Jul-2024 MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance AccessWire
22-Jul-2024 Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud AccessWire
22-Jul-2024 Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024 AccessWire
22-Jul-2024 Global Endoscopic Closure Systems Market are projected to grow to USD 570.2 million by 2033, driven by rising demand for endoscopic procedures MARKITWIRED
22-Jul-2024 Global Electric Acupuncture Devices Market Set to Grow Exponentially, With Projections of USD 27.5 Million by 2033 MARKITWIRED
22-Jul-2024 Global Dental Ceramic Market is on track to reach USD 664.9 million by 2034, growing at a consistent 5.6% CAGR MARKITWIRED
22-Jul-2024 Global Cosmetology Market is anticipated to surpass USD 316.05 billion by the year 2033 MARKITWIRED
22-Jul-2024 Global Diagnostic Exosome Biomarkers Market Set for Remarkable Growth: Projected to Reach USD 888.5 Million by 2033 MARKITWIRED
22-Jul-2024 Global Dental Service Market Predicted to Expand Significantly, with Projections of USD 696.43 Billion by 2034 MARKITWIRED
22-Jul-2024 Global Dialysis Device and Concentrates Market is set to expand to USD 34,824.85 million by 2033, with a CAGR of 4.9% MARKITWIRED
22-Jul-2024 Global Retinoid Market is expected to grow to USD 3.05 billion by 2034, driven by a CAGR of 6.5% MARKITWIRED
22-Jul-2024 Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia AccessWire
22-Jul-2024 Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia Biophytis
22-Jul-2024 Spexis expects that audit of its 2023 financials will not be completed by 31 July 2024, provides status update relating to the Company’s moratorium and changes to its Executive Committee. Spexis AG
22-Jul-2024 Nutrition at Its Core: Global Oral Clinical Nutrition Supplement Market to Exceed USD 19613.1 Million by 2033 with a 6.2% CAGR MARKITWIRED
19-Jul-2024 Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Deficiency Letter AccessWire
19-Jul-2024 Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule AccessWire
19-Jul-2024 Ottobock Leads the Charge in Expanding Access to Prosthetics for Underserved Patients AccessWire
19-Jul-2024 NICE issues draft guidance on bispecific antibody TECVAYLI®▼ (teclistamab) for eligible patients with relapsed and refractory multiple myeloma after three treatments Johnson & Johnson
19-Jul-2024 Artificial Urinary Sphincter Market At a 5.2% CAGR, it is anticipated to reach USD 760.5 million by 2033. MARKITWIRED